In 2007, people at Harvard estimated that there were roughly 200 million privately covered lives. Yesterday the AHIP census reported that about 13.5 million with private coverage had HSA/HDHP coverage, about 7 percent of the number Harvard estimates have private coverage.
So 16 percent looks pretty good. Maybe the uninsured are adding to the total. I’d be surprised if people on Medicaid, in HMOs, or on Medicare with good supplemental coverage, were concerned.
“Only 16% of patients ask about prices before care — up from 11% in 2010.”
Hey, look on the bright side… the proportion of patients inquiring about the price of medical services rose by 50% in the past year or so! That great news!
I can only imagine the public health crisis that would ensue if large numbers of counterfeit drugs were on the market in a developing nation for the purposes of treating a contagious outbreak.
Without the right mechanisms in place to stop counterfeit/ineffective drugs from being used and marketed, a real crisis could be around the corner when there is an outbreak.
In 2007, people at Harvard estimated that there were roughly 200 million privately covered lives. Yesterday the AHIP census reported that about 13.5 million with private coverage had HSA/HDHP coverage, about 7 percent of the number Harvard estimates have private coverage.
So 16 percent looks pretty good. Maybe the uninsured are adding to the total. I’d be surprised if people on Medicaid, in HMOs, or on Medicare with good supplemental coverage, were concerned.
“Only 16% of patients ask about prices before care — up from 11% in 2010.”
Hey, look on the bright side… the proportion of patients inquiring about the price of medical services rose by 50% in the past year or so! That great news!
Many millionaire’s who lose their money in recessions have their money in market bubbles.
Only 16 percent? How many of those had insurance?
I can only imagine the public health crisis that would ensue if large numbers of counterfeit drugs were on the market in a developing nation for the purposes of treating a contagious outbreak.
Without the right mechanisms in place to stop counterfeit/ineffective drugs from being used and marketed, a real crisis could be around the corner when there is an outbreak.